VisionGate Announces an Exclusive Global License, Manufacturing and Supply Agreement for Iloprost, VisionGate’s Phase 2 Oral Lung Cancer Interception Drug

Press Release, August 22, 2019

more No Comments August 22 2019

VisionGate® Presents Blinded Trial Data at WCLC 2016: Could Help Alleviate Worry Over Incidental Lung Nodule Findings

more No Comments December 16 2016

17th World Conference on Lung Cancer: VisionGate Will Present Twice!

more No Comments November 17 2016

VisionGate to speak for the exclusive Piper Jaffray Conference

more No Comments November 17 2016

VisionGate Hires Renowned Chief Medical Officer Dr. Javier Zulueta

more No Comments June 2 2016

VisionGate’s LuCED Test and New Drug Therapy to Prevent Lung Cancer

more No Comments June 1 2016

Lung Cancer Pioneers Create Lung Cancer Eradication Pact: VisionGate Acquires Exclusive Rights to University of Colorado’s Chemoprevention Drug Iloprost

more No Comments January 7 2016

VisionGate’s LuCED Shows Promise for Lung Cancer Screening

more No Comments September 11 2015

Significant Lung Cancer Screening Study Published in the American Cancer Society Journal, Cancer Cytopathology

more No Comments July 9 2015

World renowned surgeon joins VisionGate’s Medical Advisory Board

more No Comments April 1 2015

Copyright 2020 - VisionGate, Inc.